Aspen Aerogels Q2 Earnings: Revenue Down 33.8% Year-Over-Year, EPS at -$0.04

Aspen Aerogels reported Q2 revenue of $78.02 million, down 33.8% YoY, and EPS of -$0.04, compared to $0.21 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $72.07 million, representing a surprise of +8.26%. The company delivered an EPS surprise of +66.67%.

Aspen Aerogels (ASPN) reported mixed financial results for the second quarter of 2025, with revenue declining 33.8% year-over-year (YoY) to $78.02 million, and earnings per share (EPS) of -$0.04, compared to $0.21 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $72.07 million, representing a surprise of +8.26% [1]. The company delivered an EPS surprise of +66.67%.

The quarterly loss of $0.04 per share was significantly better than the Zacks Consensus Estimate of a loss of $0.12. This improvement is notable, as it represents a 66.67% earnings surprise. Over the past four quarters, Aspen Aerogels has consistently surpassed consensus EPS estimates, demonstrating a strong track record of meeting or exceeding expectations.

Aspen Aerogels' revenue decline was primarily driven by a 34% decrease in revenue from $117.77 million in the second quarter of 2024 to $78.02 million in the second quarter of 2025. The company's thermal barrier revenue grew 13% quarter-over-quarter to $55.2 million, while energy industrial revenue declined sharply by 24% to $22.8 million [2].

Despite the revenue challenges, Aspen Aerogels showed operational improvements. Gross margins improved by three percentage points quarter-over-quarter to 32%, and Adjusted EBITDA nearly doubled from the previous quarter to $9.7 million. The company also announced a CFO transition, with Ricardo Rodriguez stepping down and Grant Thoele taking over as CFO [2].

For the second half of 2025, Aspen Aerogels projects revenue of $140-160 million and Adjusted EBITDA of $20-30 million, with expected improvements in profitability due to cost structure optimization. The company maintains a strong balance sheet with $167.6 million in cash and equivalents and plans to reduce capital expenditure requirements while pursuing strategic opportunities.

The sustainability of Aspen Aerogels' stock price will depend on how the company's earnings outlook and future estimates evolve. The current consensus EPS estimate is -$0.09 on $66.42 million in revenues for the coming quarter and -$3.93 on $288.66 million in revenues for the current fiscal year [1]. Investors should monitor these estimates closely, as they can provide valuable insights into the company's near-term performance.

References:
[1] https://finance.yahoo.com/news/aspen-aerogels-aspn-reports-q2-114002078.html
[2] https://www.stocktitan.net/news/ASPN/aspen-aerogels-inc-reports-second-quarter-2025-financial-results-and-homjdunothrg.html